A macrophage-derived microvesicle loaded with dexamethasone, its preparation method and application

A technology of macrophages and dexamethasone, which is applied in the field of biomedicine to achieve a wide range of sources, extensive anti-inflammatory and immunosuppressive effects, and better therapeutic effects

Active Publication Date: 2020-08-11
SOUTHEAST UNIV
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is no report in the prior art that macrophage microvesicles are used as dexamethasone carrier to achieve anti-inflammatory treatment of kidney disease

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A macrophage-derived microvesicle loaded with dexamethasone, its preparation method and application
  • A macrophage-derived microvesicle loaded with dexamethasone, its preparation method and application
  • A macrophage-derived microvesicle loaded with dexamethasone, its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Dexamethasone-loaded macrophage-derived microvesicles Extraction, identification and drug concentration determination

[0037] 1, preparation of

[0038]The mouse macrophage cell line RAW 264.7 (purchased from the Cell Bank of the Chinese Academy of Sciences) was cultured in vitro, and the RAW264.7 cells were cultured in RIPM 1640 (Gibco, USA) medium containing 10% fetal bovine serum (Gibco, USA) by volume fraction, wherein The fetal bovine serum used was centrifuged to remove microvesicles. When the confluence of RAW 264.7 cells in the culture flask reaches 70%-80%, wash the cells twice with RIPM 1640 medium, and replace it with FBS-free RIPM 1640 medium, add DEX (Sigma, USA) to make the final concentration 30 μmol / L, treated for 16h. After 16 hours of treatment, aseptically collect the culture supernatant in a 50ml sterile centrifuge tube and centrifuge at 4°C, 2000×g for 20 minutes to remove dead cells and large debris; carefully transfer the supernatant to a ...

Embodiment 2

[0047] Dexamethasone-loaded macrophage-derived microvesicles Therapeutic effect on LPS-induced glomerular endothelial cell inflammation

[0048] 1. Uptake by glomerular endothelial cells detection

[0049] Mouse primary glomerular endothelial cells (GECs) were extracted in vitro, spread in six-well plates or confocal small dishes, and when the cell fusion reached 80%, add 2×10 7 PKH26 (US Sigma) labeled Add 5×10 to the confocal cuvette 6 PKH26-tagged Observe the uptake of GECs by LPS (final concentration 10 μg / ml) (Sigma, USA) at different time points effect, in order to observe GEC phagocytosis The amount of the average fluorescence intensity of GECs in the six-well plate was detected by flow cytometry, and the results were as follows figure 2 As shown in A, the average fluorescence intensity of GECs in the LPS intervention group (final concentration 10 μg / ml) was higher (the control group was without LPS). Observation of GEC uptake by laser confocal microscopy...

Embodiment 3

[0056] Dexamethasone-loaded macrophage-derived microvesicles Therapeutic effect on LPS-induced sepsis model in mice

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a macrophage-derived microvesicle loaded with dexamethasone, a preparation method and application thereof. The dexamethasone-loaded macrophage-derived microvesicles are formed by encapsulating dexamethasone in microvesicles derived from the mouse macrophage cell line RAW 264.7 cells. The macrophage-derived microvesicles loaded with dexamethasone of the present invention can be more effectively taken up by damaged cells, and the purpose of improving renal inflammation is achieved by inhibiting the activation of pro-inflammatory signaling pathways and the infiltration of inflammatory cells. At the same time, the preparation method of the present invention is simple, convenient and efficient, and the prepared microvesicles are derived from RAW 264.7 cells with sufficient quantity and wide sources, and can be produced in a large scale. The macrophage-derived microvesicles loaded with dexamethasone prepared in the present invention can be used in the preparation of medicines or preparations for treating kidney diseases, and can also be used in the preparation of anti-inflammatory or immunosuppressive medicines or preparations.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to a microvesicle-based drug delivery system, in particular to a method for preparing macrophage-derived microvesicles loaded with dexamethasone and its application in the anti-inflammatory treatment of kidney diseases. Background technique [0002] Glucocorticoids such as dexamethasone have been widely used in the treatment of inflammatory and immune diseases because of their significant anti-inflammatory and immune-suppressing effects. syndrome, IgA nephropathy, etc. However, long-term heavy use of glucocorticoids can lead to serious adverse reactions and glucocorticoid resistance, which seriously hinders clinical use. Therefore, exploring ways to reduce the adverse reactions of glucocorticoids and improve the sensitivity of glucocorticoids has become a research hotspot. [0003] Microvesicles are extracellular vesicles with a diameter of about 100-1000nm secreted by a variety of living ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K47/06A61K47/46A61K31/573A61P13/12A61P29/00A61P37/06
CPCA61P13/12A61P29/00A61P37/06A61K9/1278A61K9/5068A61K31/573A61K49/0091
Inventor 刘必成汤涛涛吕林莉
Owner SOUTHEAST UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap